RESEARCH PAPER
Prevalence of diabetes mellitus and IFG in the prospective cohort ‘PONS’ study – baseline assessment
 
More details
Hide details
1
Department of Social Medicine, Wroclaw Medical University, Wroclaw, Poland
2
Department of Food Science and Dietetics, Wroclaw Medical University, Wroclaw, Poland
3
Department of Dietetics, Wroclaw Medical University, Wroclaw, Poland
4
Department and Clinic of Internal and Occupational Diseases and Hypertension, Wroclaw Medical University, Wroclaw, Poland
5
Norwegian University of Science and Technology, Department of Public Health, Faculty of Medicine, University Medical Centre, Trondheim, Norway
6
Department of Cancer Epidemiology and Prevention, the Maria Skłodowska-Curie Cancer Centre and Institute of Oncology, Warsaw, Poland
7
European Health Inequalities Observatory, Institute of Rural Health, Lublin, Poland
 
Ann Agric Environ Med. 2011;18(2):265–269
KEYWORDS
ABSTRACT
Objective:
The aim of this cross-sectional study was to assess the prevalence of diabetes mellitus and impaired fasting glucose (IFG) in the Polish-Norwegian Study (PONS) population in Poland.

Material and Methods:
The presented results are part of the PONS project, and cover information from 3,854 people aged 45-64 (2,567 females and 1,287 males) who are inhabitants of Świętokrzyski Province.

Results:
In the study group there were 62.8% participants with normoglycaemia, 28.9% participants with IFG and 8.4% participants with diabetes. In those with diabetes, there were 95 participants (2.5%) whose diabetes was unknown prior to this study. Among 5.9% patients with known diabetes 52.9% of the participants had a fasting blood glucose level of ≥126 mg%. There were 46.8% males and 70.8% females with normoglycaemia, 41.0% males and 22.8% females with IFG, and 12.2% males and 6.4% females with diabetes. The prevalence of diabetes was higher in participants in the older age group (55-64) compared to younger participants (45-54). The prevalence of diabetes decreased with increasing education and was higher among overweight or obese participants compared to normal weight participants.

Conclusions:
The prevalence of diabetes mellitus in study population was generally high, but especially high in males, and the awareness of diabetes in the population was generally low. Among participants with known diabetes more than half was not well controlled.

 
REFERENCES (19)
1.
Boyle J, Honeycutt A, Narayan K. Projection of diabetes burden through 2050. Diabetes Care 2001;24:1936-1940.
 
2.
Simmons RK, Unwin N, Griffi n SJ. International Diabetes Federation: an update of the evidence concerning the prevention of type 2 diabetes. IDF Diabetes Atlas (4th ed.) 2009.
 
3.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes. Diabetes Care 2004;27:1047-1053.
 
4.
Website of World Health Organization http://www.who.int/diabetes/en (WHO) (accessed 10.10. 2011).
 
5.
Sicree R, Shaw J, Zimmet P. Th e Global Burden, Diabetes and Impaired Glucose Tolerance, IDF Diabetes Atlas (4th ed.) 2009:1-15.
 
6.
Nowakowski A. Epidemiologia cukrzycy. Diabetol Prakt 2002;3:181- 185.
 
7.
Sieradzki J (Ed.). Cukrzyca. Wydawnictwo Via Medica, Gdańsk 2006.
 
8.
Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Wybrane czynniki ryzyka chorób sercowo-naczyniowych u pacjentów POZ, Nadciśn Tętn 2006;10:370-376.
 
9.
Zatoński W, (Eds.) with: Mańczuk M, Sulkowska U, and the HEM Project team. Closing the health gap in European Union. Cancer Center and Institute of Oncology, Warsaw 2008.
 
10.
Podolec P, Karch I, Pająk A, Kopeć G, Broda G, Drygas W, et al. Przegląd polskich badań epidemiologicznych w kardiologii. Kardiol Pol 2006;64:1031-1037.
 
11.
Szybiński Z. Polskie Wieloośrodkowe Badania nad Epidemiologią Cukrzycy (PWBEC) -1998-2000. Pol Arch Med Wewn 2001;3:751-91.
 
12.
Zdrojewski T, Bandosz P, Szpakowski P et al. Ocena wybranych problemów dotyczących wybranych terapii nadciśnienia tętniczego w Polsce na podstawie badania NATPOL III PLUS, In: Więcek A, Kokot F (Ed.): Postępy w nefrologii i nadciśnieniu tętniczym. T. II. Medycyna Prakt, Kraków 2003:11-15.
 
13.
Fraser LA, Twombly J, Long Q, Hanfelt JJ, Narayan VKM, Wilson PWF, Philips LS. Delay In diagnosis In diabetes is not the patient’s fault, Diabetes Care 2010, 33, doi: 10.2337/dc09-1129.
 
14.
Korzeniowska K, Jabłecka A. Cukrzyca (część I). Farmacja współczesna 2008;1:231-235.
 
15.
Majkowska L, Czekalski S. Cukrzyca, In: Januszewicz W, Kokot F (Ed.). Interna.Wydawnictwo Lekarskie PZWL, Warsaw 2002:1089-1129.
 
16.
Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention, Diabet Med 2007;24:451- 463.
 
17.
Pangiotakos DB, Pitsavost C, Chrysohoout C, Stefanadist C. Th e epidemiology of type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005;22:1581-1588.
 
18.
Matthews DR, Matthews PC. Banting memorial lecture 2010. Type 2 diabetes as an ‘infectious’ disease: is this the Black Death of the 21st century? Diabet Med 2011;28:2-9.
 
19.
Wojtyła A, Biliński P, Jaworska-Łuczak B. Regulatory strategies to ensure food and feed safety in Poland – update review. Ann Agric Environ Med 2010;17:215–220.
 
eISSN:1898-2263
ISSN:1232-1966